Authors


John Lauerman

Recent and archived articles by John Lauerman

16 Apr 2019 | 3:00 PM

AI test pinpoints more cancers targeted by Astra, Glaxo drugs

Using artificial intelligence to pinpoint tumour cells with reduced ability to repair their own DNA can help identify tens of thousands of patients who would benefit from treatment with drugs from AstraZeneca Plc and GlaxoSmithKline Plc, researchers said.

22 Nov 2018 | 2:30 PM

Google taking over health records raises patient privacy fears

Three years ago, artificial intelligence company DeepMind embarked on a landmark effort to transform health care in the UK. Now plans by owner Alphabet Inc to wrap the partnership into its Google search engine business are tripping alarm bells about privacy.

Members of clinical staff working at computers at a hospital in Wigan, England. Data protection advocates cried foul when the company reversed course on an earlier pledge to keep DeepMind Health, which taps millions of British medical records to monitor and diagnose disease, separate from Google. — AFP
11 Oct 2018 | 12:31 PM

Gates Foundation backs self-checkup app’s Africa expansion

A free app that lets patients do quick health checkups on themselves is the centrepiece of a Gates Foundation-backed project to bring better care to poor regions of Africa, Asia and South America.

The English version of the Ada app. — Ada
17 Nov 2017 | 3:30 PM

Drug companies are warming up to the idea of an Amazon pharmacy

The market is buzzing with speculation that Amazon.com Inc will enter the pharmacy business. Some drugmakers are just fine with changes the tech retail giant might bring to the complex market.